5-(3-(4-CHLOROPHENYL)-1,2-OXAZOL-5-YL)-1-((2R,4S,5R)-4-HYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE
UNII VP2MJB57WA
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(3-(4-chlorophenyl)-1,2-oxazol-5-yl)-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VP2MJB57WA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 133040-30-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H16ClN3O6 RDWMBXVEAYEJBQ-NUEKZKHPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(3-(4-chlorophenyl)-1,2-oxazol-5-yl)-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.